Monthly Archives: June 2025

//June

Medicine Supply Notification: Venlafaxine 37.5mg modified-release tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Venlafaxine 37.5mg modified-release tablets. MSN/2025/035 Tier 2 – medium impact Date of issue: 13th June 2025 Venlafaxine 37.5mg modified release (MR) tablets are out of stock until mid-July 2025. Venlafaxine 37.5mg MR capsules remain available and can support increased demand. Venlafaxine [...]

The post Medicine Supply Notification: Venlafaxine 37.5mg modified-release tablets appeared first on Community Pharmacy England.

By |June 13th, 2025|Lexpos News|Comments Off on Medicine Supply Notification: Venlafaxine 37.5mg modified-release tablets

Yorkshire and North Eastern Pharmacy Owners: Book on your local Future of Pharmacy workshop

With the conclusion of the NHS 10-Year Health Plan imminent, this is a critical time for community pharmacy and it is important that we focus on the future, including looking at negotiating priorities to further leverage community pharmacy’s position. Pharmacy owners across Yorkshire and the Humber and the North East are invited to ‘Future of [...]

The post Yorkshire and North Eastern Pharmacy Owners: Book on your local Future of Pharmacy workshop appeared first on Community Pharmacy England.

By |June 13th, 2025|Lexpos News|Comments Off on Yorkshire and North Eastern Pharmacy Owners: Book on your local Future of Pharmacy workshop

MHRA Class 2 Medicines Recall: Inhixa 12,000IU (120mg)/0.8mL solution for injection (Maxearn Limited)

MHRA Class 2 Medicines Notification: Inhixa 12,000IU (120mg)/0.8mL solution for injection (Maxearn Limited) Drug alert number: EL(25)A/27 Date issued: 12 June 2025 Maxearn Limited have informed the MHRA that the carton used to package two imported batches of Inhixa have been released to the market with a typographical error on one side of the carton. [...]

The post MHRA Class 2 Medicines Recall: Inhixa 12,000IU (120mg)/0.8mL solution for injection (Maxearn Limited) appeared first on Community Pharmacy England.

By |June 12th, 2025|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: Inhixa 12,000IU (120mg)/0.8mL solution for injection (Maxearn Limited)

DMS: Shortened claim journey on MYS from July 2025

A new streamlined process for making claims for the Discharge Medicines Service (DMS) will come into effect from 6th July 2025. Following feedback from Community Pharmacy England about the current lengthy claim process, NHS England and NHSBSA have agreed to introduce a shortened process for making claims for DMS. In time, an API will be [...]

The post DMS: Shortened claim journey on MYS from July 2025 appeared first on Community Pharmacy England.

By |June 12th, 2025|Lexpos News|Comments Off on DMS: Shortened claim journey on MYS from July 2025

Pfizer brands now available as generics

Pharmacy teams should be aware that Pfizer Limited has recently ceased supplying a number of its well-established brands and released generic equivalent versions instead. The table below includes the Pfizer products that have recently transitioned from brand to generic along with information on ordering codes and list prices. Branded Product Name Generic Product Name Generic [...]

The post Pfizer brands now available as generics appeared first on Community Pharmacy England.

By |June 11th, 2025|Lexpos News|Comments Off on Pfizer brands now available as generics